Systemic treatment of recurrent candidal vulvovaginitis by Itraconazole.

Abstract

20 women suffering from recurrent candidal vulvovaginitis were treated with Itraconazole, with a single oral dose of 200 mg/day administered after the main meal for three days. The diagnosis was obtained by microscope and culture tests, and check were made 7 and 30 days after completion of the treatment. The symptom score, assessed on the individual patients by means of the classic clinical parameters, showed a significant drop both at the first and second level checks. In our study, the culture tested negative in 75% of cases at the first check, and in 85% of cases at the second check. All patients completed the study without claiming any major side effects.

• Authors: A Azzena, F Vasoin
• Journal: Clinical and experimental obstetrics & gynecology (Clin Exp Obstet Gynecol) Vol. 21 Issue 1 Pg. 59-62 ( 1994) ISSN: 0390-6663 [Print] Singapore
• PMID: 8020181 (Publication Type: Journal Article)

Chemical References

• Itraconazole

Topics

• Administration, Oral
• Adolescent
• Adult
• Candidiasis, Vulvovaginal (drug therapy, microbiology)
• Female
• Humans
• Itraconazole (administration & dosage, therapeutic use)
• Middle Aged
• Recurrence